The relationship between CD34+ stem cell dose and time to neutrophil recovery in autologous haematopoietic stem cell recipients—A single centre experience
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference18 articles.
1. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides;D’Souza,2016
2. Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation;D’Rozario;Transfus Apher Sci,2014
3. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100);Giralt;Leukemia,2009
4. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients;Tricot;Blood,1995
5. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma;Stiff;Biol Blood Marrow Transplant,2011
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Báo cáo các trường hợp bệnh nhân đa u tủy xương được ghép tế bào gốc tạo máu tự thân tại Bệnh viện Trung ương Huế;Journal of Clinical Medicine- Hue Central Hospital;2024-01-02
2. The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients;Transfusion and Apheresis Science;2021-10
3. Early infection in post-autologous hematopoietic stem cell transplant patients;Saudi Medical Journal;2021-08
4. Association of CD 34 positive cell dose with engraftment kinetics in autologous peripheral blood stem cell transplant patients of multiple myeloma;Medical Journal Armed Forces India;2021-03
5. Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?;Journal of Oncology Pharmacy Practice;2020-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3